Major Depressive Disorder(Adults)
Major Depressive Disorder(Pediatric)
MaJor Depressive Disorder- Treatment Resistant
Observational study for patients using Aripiprazole or Risperidon
Major Depressive Disorder (7-17)
Is your child troubled by depression? If your child is affected by depression and still experiencing its symptoms - you may be interested in the Kites study.
Aged between 7 and 17
Diagnosed with major depressive disorder (MDD)
Being treated for MDD as an outpatient
Major Depressive Disorder (7-17 )
Qualifying participants must be:
12-17 years of age
Adolescent Schizophrenia
Qualifying participants must be:
13-17 years of age
Have current symptoms or diagnosis of schizophrenia for at least 6 months
Require treatment with antipsychotic medication(s)
Observational
You may qualify if you are:
1. 3-18 years old
2. Receiving Aripiprazole (Abilify) or Risperidone (Perseris)
Upcoming Studies for Men & Women
Click to add your name to be considered for future studies. We will contact you to discuss new study opportunities. Please provide your email address if possible.
Adolescent ADHD
Qualifying participants must be:
4-5 years and 9 months of age
Have a prior diagnosis of ADHD
ADHD Symptoms that are not well controlled on current ADHD Medications
Chronic Migraines(6-17)
Qualifying participants must be:
6-17 years of age
Clinical History of 6 months or Greater
15 or more headaches per month
Chronic Migraines(6-17)
Qualifying participants must be:
6-17 years of age
Clinical History of 6 months or Greater
Greater than or Equal to 14 Migraines per month X 3 months
Major Depressive Disorder
Qualifying participants must be:
18-75 years of age
Currently experiencing a moderate to severe episodes of depression
Major Depressive Disorder
Qualifying participants must be:
18 years of age and older
Failed Response of 2 or more oral antidepressant Medications
